| 2019 | | A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status | 김순선, 김진홍, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조효정, 황재철 |
| 2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
| 2021 | | Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Radiologic and clinical factors predictive of survival | 권요한, 김재근, 김진우, 원제환, 조효정, 허지미 |
| 2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2007 | | Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. | 강석윤, 강승희, 김장희, 김효철, 박준성, 신승수, 오영택, 이광재, 이현우, 전미선, 최진혁, 한재호 |
| 2020 | | MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma | 김순선, 우현구, 은정우, 정재연, 조효정, 최지혜 |
